Nektar Therapeutics logo
Nektar Therapeutics NKTR
$ 1.05 3.47%

Annual report 2023
added 03-05-2024

report update icon

Nektar Therapeutics Financial Ratios 2011-2024 | NKTR

Annual Financial Ratios Nektar Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.6 -0.7 -3.9 -7.9 -8.1 10.7 -133.0 -10.7 -22.3 -34.5 -10.0 -5.7 -5.4

P/S

1.9 2.8 20.0 23.0 31.0 6.1 41.8 9.9 7.8 9.3 10.9 12.0 10.1

EPS

-1.4 -2.0 -2.9 -2.5 -2.5 4.0 -0.6 -1.1 -0.6 -0.4 -1.4 -1.5 -1.2

EV (Enterprise Value)

399 M 516 M 2.45 B 3.78 B 4.03 B 7.55 B 13.3 B 2.06 B 2.25 B 2.25 B 2.1 B 1.4 B 1.11 B

EBITDA per Share

-1.35 -1.94 -2.36 -2.31 -2.44 4.12 -0.185 -0.698 -0.125 -0.028 -0.915 -1.09 -0.965

EV/EBITDA

-5.6 -9.8 -8.7 10.5 -452.9 -18.7 -120.7 -553.7 -16.1 -8.6 -8.4

PEG

0.01 0.0 0.01 0.02 0.05 0.01 -3.05 0.13 0.49 -0.49 -1.5 0.22 0.03

P/B

1.3 0.7 3.0 3.3 2.5 4.3 146.4 18.6 281.0 51.1 -18.0 20.8 3.6

P/CF

-0.9 -0.9 -4.9 -11.2 -10.0 10.4 -142.7 -13.3 -21.4 -12.2 -38.0 -7.0 -5.8

ROE %

-210.75 -100.43 -77.09 -41.26 -31.36 39.67 -110.09 -174.21 -1262.67 -148.40 180.21 -365.51 -67.73

ROA %

-69.36 -51.82 -46.89 -28.88 -22.29 31.69 -19.00 -26.99 -16.17 -12.21 -37.28 -34.52 -22.09

ROCE %

-201.31 -102.60 -65.65 -39.46 -27.10 33.26 -9.64 -22.72 -6.66 -4.37 -35.72 -33.28 -37.44

Current Ratio

1.5 2.1 2.6 3.3 4.0 17.5 5.8 5.9 5.7 4.5 2.6 4.0 1.0

DSO

14.6 56.4 109.9 90.3 117.2 13.2 5.9 34.6 31.5 6.6 5.5 26.1 25.2

DIO

190.8 295.3 227.9 262.0 216.3 170.2 128.2 134.2 121.4 165.7 127.5 219.1 211.0

DPO

123.4 191.7 233.7 387.7 328.5 87.5 57.1 34.0 25.3 34.6 86.4 34.3 50.3

Operating Cycle

205.3 351.7 337.8 352.3 333.5 183.4 134.1 168.8 153.0 172.2 133.0 245.2 236.2

Cash Conversion Cycle

82.0 160.0 104.1 -35.4 5.0 95.9 77.0 134.8 127.7 137.7 46.6 210.9 185.9

All numbers in USD currency

Quarterly Financial Ratios Nektar Therapeutics

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- -0.31 - -0.49 -790 -0.7 -690 -0.68 -0.65 -0.61 -0.45 -0.78 -0.64 -0.56 -0.63 -0.69 -0.57 -0.56 5.67 -0.6 -0.21 0.39 -0.39 -0.42 -0.28 -0.32 -0.36 -0.14 -0.4 -0.06 -0.4 0.26 -0.35 0.55 -0.26 -0.37 -0.41 -0.14 -0.37 -0.48 -0.46 -0.38 -0.3 -0.36 -0.33 -0.21 -0.32 -0.33

EBITDA per Share

- -0.24 - -0.61 -0.61 -0.56 -0.6 -0.58 -0.61 -0.51 -0.39 -0.73 -0.62 -0.51 -0.6 -0.68 -0.58 -0.53 5.71 -0.52 -0.15 0.52 -0.27 -0.33 -0.21 -0.16 -0.23 -0.04 -0.22 0.07 -0.29 0.35 -0.29 0.71 -0.13 -0.27 -0.31 0.04 -0.22 -0.36 -0.38 -0.19 -0.17 -0.3 -0.3 -0.09 -0.23 -0.26

ROE %

-44.06 -65.50 -52.49 -66.36 -63.85 -53.30 -47.19 -40.75 -41.26 -38.36 -35.29 -35.71 -31.36 -29.09 -27.68 36.73 39.67 6.87 81.78 -42.95 -110.09 -119.46 -237.82 -224.80 -174.21 -968.40 -1046.95 -1810.85 -1262.67 -546.33 -224.41 504.82 -148.40 30.35 -145.58 -8.20 180.21 14.63 -96.39 -216.85 -365.51 -271.90 -191.45 -136.92 -67.73 -12.17 -18.39 -18.22

ROA %

-25.21 -38.25 -32.02 -41.17 -40.79 -35.37 -32.27 -28.31 -28.88 -26.94 -24.87 -25.25 -22.29 -21.18 -20.67 30.09 31.69 29.61 46.04 -10.91 -19.00 -19.77 -39.33 -36.11 -26.99 -30.43 -24.47 -26.49 -16.28 -15.77 1.87 5.04 -12.21 -12.83 -32.63 -35.07 -37.28 -36.95 -41.89 -38.94 -34.52 -30.07 -25.29 -24.40 -22.09 -3.97 -6.00 -5.94

ROCE %

-51.52 -68.14 -49.96 -62.14 -53.97 -47.63 -43.02 -38.06 -39.46 -36.98 -34.44 -35.13 -31.31 -29.35 -28.07 36.52 40.05 18.53 103.38 -10.98 -67.91 -77.02 -193.47 -179.28 -128.06 -548.33 -504.48 -1137.13 -456.85 -103.29 111.27 724.33 -45.37 97.73 -116.08 -16.74 133.62 1.43 -75.80 -169.47 -300.31 -225.47 -166.29 -126.21 -62.65 -10.79 -17.32 -17.12

Current Ratio

- 2.1 - 2.5 2.5 2.7 2.9 3.1 3.3 3.3 3.3 3.3 3.5 3.5 3.5 3.5 5.0 5.0 5.0 5.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 0.8 0.8 0.8 0.8 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5

DSO

- 22.3 - 96.9 93.9 105.9 93.5 131.3 151.2 118.2 72.7 68.3 99.2 114.9 144.0 129.4 64.5 92.5 3.6 57.9 4.8 3.0 13.2 38.2 38.2 39.4 43.7 27.6 46.2 30.4 80.3 9.9 16.8 2.5 11.5 13.5 6.5 3.3 6.0 15.9 25.1 28.8 22.4 27.3 28.6 16.6 26.0 -

DIO

- 174.9 - 267.7 230.5 257.3 187.0 254.4 322.8 250.5 241.7 334.7 193.0 234.6 230.3 201.7 139.2 217.1 188.1 151.8 100.3 172.5 108.9 162.5 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- 48.9 - 192.0 247.3 372.5 250.7 353.3 467.3 362.7 349.9 495.3 293.1 356.2 349.8 210.4 71.6 111.7 96.7 73.0 44.7 76.9 48.5 56.5 - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- 197.1 - 364.6 324.4 363.2 280.4 385.7 474.0 368.7 314.4 403.0 292.1 349.5 374.4 331.0 203.7 309.7 191.7 209.7 105.1 175.5 122.1 200.7 38.2 39.4 43.7 27.6 46.2 30.4 80.3 9.9 16.8 2.5 11.5 13.5 6.5 3.3 6.0 15.9 25.1 28.8 22.4 27.3 28.6 16.6 26.0 -

Cash Conversion Cycle

- 148.2 - 172.6 77.1 -9.3 29.7 32.4 6.7 6.0 -35.6 -92.3 -0.9 -6.7 24.6 120.6 132.1 198.0 95.0 136.6 60.4 98.6 73.6 144.1 38.2 39.4 43.7 27.6 46.2 30.4 80.3 9.9 16.8 2.5 11.5 13.5 6.5 3.3 6.0 15.9 25.1 28.8 22.4 27.3 28.6 16.6 26.0 -

All numbers in USD currency